These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 33381671)

  • 1. Intersection of Polycystic Ovary Syndrome and the Gut Microbiome.
    Rizk MG; Thackray VG
    J Endocr Soc; 2021 Feb; 5(2):bvaa177. PubMed ID: 33381671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota.
    Yurtdaş G; Akdevelioğlu Y
    J Am Coll Nutr; 2020; 39(4):371-382. PubMed ID: 31513473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to a Healthy Gut Microbiome Protects Against Reproductive and Metabolic Dysregulation in a PCOS Mouse Model.
    Torres PJ; Ho BS; Arroyo P; Sau L; Chen A; Kelley ST; Thackray VG
    Endocrinology; 2019 May; 160(5):1193-1204. PubMed ID: 30924862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiome and Polycystic Ovary Syndrome: Interplay of Associated Microbial-Metabolite Pathways and Therapeutic Strategies.
    Babu A; Devi Rajeswari V; Ganesh V; Das S; Dhanasekaran S; Usha Rani G; Ramanathan G
    Reprod Sci; 2024 Jun; 31(6):1508-1520. PubMed ID: 38228976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota and Polycystic Ovary Syndrome (PCOS): Understanding the Pathogenesis and the Role of Probiotics as a Therapeutic Strategy.
    Salehi S; Allahverdy J; Pourjafar H; Sarabandi K; Jafari SM
    Probiotics Antimicrob Proteins; 2024 Oct; 16(5):1553-1565. PubMed ID: 38421576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbes in Polycystic Ovary Syndrome and Associated Comorbidities; Type 2 Diabetes, Non-Alcoholic Fatty Liver Disease (NAFLD), Cardiovascular Disease (CVD), and the Potential of Microbial Therapeutics.
    Singh V; Mahra K; Jung D; Shin JH
    Probiotics Antimicrob Proteins; 2024 Oct; 16(5):1744-1761. PubMed ID: 38647957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal microbiota transplantation from patients with polycystic ovary syndrome induces metabolic disorders and ovarian dysfunction in germ-free mice.
    Huang F; Deng Y; Zhou M; Tang R; Zhang P; Chen R
    BMC Microbiol; 2024 Sep; 24(1):364. PubMed ID: 39333864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics.
    Singh S; Pal N; Shubham S; Sarma DK; Verma V; Marotta F; Kumar M
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice.
    Zhang H; Zheng L; Li C; Jing J; Li Z; Sun S; Xue T; Zhang K; Xue M; Cao C; Ouyang L; Qian Z; Xu R; He Z; Ma R; Chen L; Yao B
    J Ovarian Res; 2023 Jul; 16(1):138. PubMed ID: 37443082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study.
    Zeng B; Lai Z; Sun L; Zhang Z; Yang J; Li Z; Lin J; Zhang Z
    Res Microbiol; 2019; 170(1):43-52. PubMed ID: 30292647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal relationship between alterations in the gut microbiome and the development of polycystic ovary syndrome-like phenotypes in prenatally androgenized female mice.
    Kusamoto A; Harada M; Azhary JMK; Kunitomi C; Nose E; Koike H; Xu Z; Urata Y; Kaku T; Takahashi N; Wada-Hiraike O; Hirota Y; Koga K; Fujii T; Osuga Y
    FASEB J; 2021 Nov; 35(11):e21971. PubMed ID: 34653284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interplay between PCOS pathology and diet on gut microbiota in a mouse model.
    Rodriguez Paris V; Wong XYD; Solon-Biet SM; Edwards MC; Aflatounian A; Gilchrist RB; Simpson SJ; Handelsman DJ; Kaakoush NO; Walters KA
    Gut Microbes; 2022; 14(1):2085961. PubMed ID: 35787106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perturbations in gut microbiota composition in patients with polycystic ovary syndrome: a systematic review and meta-analysis.
    Li P; Shuai P; Shen S; Zheng H; Sun P; Zhang R; Lan S; Lan Z; Jayawardana T; Yang Y; Zhao J; Liu Y; Chen X; El-Omar EM; Wan Z
    BMC Med; 2023 Aug; 21(1):302. PubMed ID: 37559119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproductive and Behavior Dysfunction Induced by Maternal Androgen Exposure and Obesity Is Likely Not Gut Microbiome-Mediated.
    Lindheim L; Manti M; Fornes R; Bashir M; Czarnewski P; Diaz OE; Seifert M; Engstrand L; Villablanca EJ; Obermayer-Pietsch B; Stener-Victorin E
    J Endocr Soc; 2018 Dec; 2(12):1363-1380. PubMed ID: 30534630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study.
    Lindheim L; Bashir M; Münzker J; Trummer C; Zachhuber V; Leber B; Horvath A; Pieber TR; Gorkiewicz G; Stadlbauer V; Obermayer-Pietsch B
    PLoS One; 2017; 12(1):e0168390. PubMed ID: 28045919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut microbial composition in polycystic ovary syndrome with insulin resistance: findings from a normal-weight population.
    He F; Li Y
    J Ovarian Res; 2021 Mar; 14(1):50. PubMed ID: 33773586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of metabolic and microbial influences on women with polycystic ovarian syndrome.
    Ravat FK; Goswami JR; Nair SM; Thummar KN
    Steroids; 2024 Dec; 212():109512. PubMed ID: 39278517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome.
    Su YN; Wang MJ; Yang JP; Wu XL; Xia M; Bao MH; Ding YB; Feng Q; Fu LJ
    Front Endocrinol (Lausanne); 2023; 14():1122709. PubMed ID: 36814581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review.
    Mukherjee AG; Wanjari UR; Kannampuzha S; Murali R; Namachivayam A; Ganesan R; Dey A; Babu A; Renu K; Vellingiri B; Ramanathan G; Priya Doss C G; Elsherbiny N; Elsherbini AM; Alsamman AM; Zayed H; Gopalakrishnan AV
    Metabolites; 2023 Jan; 13(1):. PubMed ID: 36677054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbial Diversity in Women With Polycystic Ovary Syndrome Correlates With Hyperandrogenism.
    Torres PJ; Siakowska M; Banaszewska B; Pawelczyk L; Duleba AJ; Kelley ST; Thackray VG
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1502-1511. PubMed ID: 29370410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.